Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

GeoVax Labs (GOVX) EBT Margin (2016 - 2025)

Historic EBT Margin for GeoVax Labs (GOVX) over the last 15 years, with Q2 2025 value amounting to 630.05%.

  • GeoVax Labs' EBT Margin rose 10541700.0% to 630.05% in Q2 2025 from the same period last year, while for Sep 2025 it was 754.69%, marking a year-over-year increase of 323900.0%. This contributed to the annual value of 631.98% for FY2024, which is N/A changed from last year.
  • GeoVax Labs' EBT Margin amounted to 630.05% in Q2 2025, which was up 10541700.0% from 327.31% recorded in Q1 2025.
  • GeoVax Labs' EBT Margin's 5-year high stood at 208.48% during Q3 2024, with a 5-year trough of 8331.01% in Q4 2021.
  • For the 4-year period, GeoVax Labs' EBT Margin averaged around 2480.75%, with its median value being 1549.78% (2024).
  • Per our database at Business Quant, GeoVax Labs' EBT Margin plummeted by -77998500bps in 2021 and then skyrocketed by 10541700bps in 2025.
  • Over the past 4 years, GeoVax Labs' EBT Margin (Quarter) stood at 8331.01% in 2021, then surged by 64bps to 2977.6% in 2022, then skyrocketed by 68bps to 955.87% in 2024, then surged by 34bps to 630.05% in 2025.
  • Its last three reported values are 630.05% in Q2 2025, 327.31% for Q1 2025, and 955.87% during Q4 2024.